Opportunity Information: Apply for RFA PS 11 002
Apply for RFA PS 11 002
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Addressing Global TB Prevention And Control In All Populations And Strengthening Health Facilities, Laboratories, Prisons And Other Community Settings" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.947 Tuberculosis Demonstration, Research, Public and Professional Education.
- This funding opportunity was created on Dec 3, 2010 and posted on Nov 8, 2010.
- Applicants must submit their applications by Feb 14, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $7,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The U.S. Civilian Research and Development Foundation is the only organization that can meet all the requirements in each of the 30 plus countries that CDC provides technical TB support and assistance, cited in the full announcement document.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (RFA PS 11 002) is a CDC discretionary cooperative agreement focused on strengthening global tuberculosis prevention, control, treatment, and research activities across a wide range of settings and populations. The project is framed as an international, multi-country effort intended to support work in as many as 35 countries where CDC already provides technical tuberculosis assistance. The overall emphasis is not just on clinical care, but on the full chain of TB control: prevention and early detection, effective treatment and patient support, and system-level improvements that make TB services more reliable in everyday practice. The title highlights priority environments such as health facilities, laboratories, prisons, and other community settings, signaling an intent to reach high-risk groups and places where TB transmission, delayed diagnosis, and treatment interruption are more likely.
The mechanism is a cooperative agreement, which generally means CDC expects to have substantial involvement in the work as it is carried out, rather than simply providing funds with minimal engagement. Under this structure, the U.S. Civilian Research and Development Foundation (CRDF) is positioned as the central implementing partner. CRDFs core function in this announcement is to initiate and manage a diverse portfolio of TB-related research and programmatic activities and to serve as the fiduciary and administrative hub for moving funds to on-the-ground implementers. In practical terms, CRDF would handle grant administration and financial oversight and then disburse funds to sub-recipients that can include foreign governmental organizations, foreign non-governmental organizations, and individuals, as well as U.S.-based non-governmental organizations or individuals. This arrangement is designed to make it easier for CDC to support many different activities across multiple countries while maintaining consistent financial management and administrative controls.
The technical scope is anchored in the work of CDCs Division of Tuberculosis Elimination, specifically its International Research and Programs Branch, which spans both research and applied public health programming. That includes activities aimed at improving TB control, strengthening treatment and prevention strategies, and supporting operational or implementation research that can improve how TB programs function. The mention of laboratories and health facilities points to common bottlenecks in TB control, such as diagnostic capacity, specimen transport and quality assurance, infection control practices, and timely linkage to treatment. The explicit inclusion of prisons and community settings reflects recognition that congregate environments and underserved communities can amplify TB transmission and that TB programs often need tailored approaches to reach people who face barriers to care.
In terms of funding, CDC listed an estimated total funding amount of $7,000,000 for the opportunity, with an award ceiling of $1,500,000 and no stated award floor. Only one award was expected, which aligns with the model of selecting a single organization to manage and distribute funds to a broader set of sub-awards. There is no cost sharing or matching requirement. The opportunity is associated with CFDA 93.947 (Tuberculosis Demonstration, Research, Public and Professional Education), indicating that funded work can include demonstration projects, research, and education or training components relevant to TB.
Eligibility is essentially restricted to CRDF. The announcement states that CRDF is the only organization that can meet the requirements spanning the 30-plus countries in which CDC provides technical TB support and assistance. That limitation helps explain why the grant is structured as a single cooperative agreement with one primary recipient that then re-grants or subcontracts to many implementing entities globally. Key dates show the opportunity was posted on November 8, 2010, created on December 3, 2010, and had its closing date extended from January 10, 2011 to February 14, 2011, with an archive date of February 15, 2011.
For applicants or stakeholders seeking more detail, the notice directs readers to the full announcement (linked through the posting) for the complete technical requirements and country-specific expectations. For access issues, CDCs Procurement and Grants Office Technical Information Management Section (TIMS) is listed as the point of contact at 770-488-2700.
Funding Opportunity RFA PS 11 002 - FAQ
What is this funding opportunity?
This is a CDC discretionary cooperative agreement (RFA PS 11 002) focused on strengthening global tuberculosis (TB) prevention, control, treatment, and research activities across multiple countries and settings.
What is the main goal of the project described in the announcement?
The project aims to improve the full chain of TB control, including prevention and early detection, effective treatment and patient support, and system-level improvements that make TB services more reliable in real-world practice.
Is the work limited to clinical treatment, or does it include other TB activities?
It is not limited to clinical care. The emphasis includes prevention, early detection, treatment support, and broader improvements in TB service delivery systems.
What types of settings are prioritized?
The announcement highlights health facilities, laboratories, prisons, and other community settings, reflecting an intent to reach high-risk environments where transmission, delayed diagnosis, and treatment interruption may be more likely.
How many countries could be involved?
The effort is framed as an international, multi-country project intended to support work in as many as 35 countries where CDC already provides technical TB assistance.
What CDC program is this work connected to?
The technical scope is anchored in CDC's Division of Tuberculosis Elimination, specifically its International Research and Programs Branch, which covers both research and applied public health programming.
What is a cooperative agreement in this context?
A cooperative agreement generally means CDC expects to have substantial involvement in the work as it is carried out, rather than providing funds with minimal engagement.
Who is expected to be the main implementing partner?
The U.S. Civilian Research and Development Foundation (CRDF) is positioned as the central implementing partner under this announcement.
What role does CRDF play under this opportunity?
CRDF is expected to initiate and manage a portfolio of TB-related research and programmatic activities and to serve as the fiduciary and administrative hub for moving funds to on-the-ground implementers, including grant administration, financial oversight, and disbursement to sub-recipients.
Can funds be provided to organizations or individuals beyond the primary recipient?
Yes. The structure is designed for CRDF to disburse funds to sub-recipients, which can include foreign governmental organizations, foreign non-governmental organizations, and individuals, as well as U.S.-based non-governmental organizations or individuals.
Why is the award structured as a single cooperative agreement?
Only one award was expected, which aligns with selecting a single organization to manage and distribute funds to a broader set of sub-awards across many countries while maintaining consistent financial management and administrative controls.
Who is eligible to apply as the primary applicant?
Eligibility is restricted to CRDF. The announcement states CRDF is the only organization that can meet the multi-country requirements spanning the 30-plus countries in which CDC provides technical TB support and assistance.
What is the estimated total funding amount for this opportunity?
CDC listed an estimated total funding amount of $7,000,000.
What is the maximum award amount (award ceiling)?
The award ceiling is $1,500,000.
Is there a minimum award amount (award floor)?
No award floor is stated in the information provided.
How many awards will be made?
Only one award was expected.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA 93.947 (Tuberculosis Demonstration, Research, Public and Professional Education).
What kinds of activities can CFDA 93.947 cover in this context?
Based on the CFDA title provided, funded work can include demonstration projects, research, and public or professional education and training components relevant to TB.
What kinds of technical bottlenecks does the announcement suggest may be addressed?
The mention of laboratories and health facilities points to common TB control bottlenecks such as diagnostic capacity, specimen transport, quality assurance, infection control practices, and timely linkage to treatment.
Why does the announcement explicitly mention prisons and community settings?
It reflects recognition that congregate environments and underserved communities can amplify TB transmission and that TB programs often need tailored approaches to reach people facing barriers to care.
What were the key dates for this opportunity?
The opportunity was posted on November 8, 2010, created on December 3, 2010, and the closing date was extended from January 10, 2011 to February 14, 2011. The archive date is February 15, 2011.
Where should someone look for full technical requirements and country-specific expectations?
The notice directs readers to the full announcement (linked through the posting) for complete technical requirements and country-specific expectations.
Who is the point of contact for access issues related to the announcement?
For access issues, the listed point of contact is CDC's Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: Major Research Instrumentation Program
Previous opportunity: Software Development for Cyberinfrastructure
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA PS 11 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA PS 11 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Patient Safety and Medical Liability Reform Planning Projects (R21) Apply for PAR 11 023 Funding Number: PAR 11 023 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Addressing TB Control And Lung Health Activities Through The Vietnam National Lung Hospital/National TB Program (NLH/NTP) Apply for RFA PS 11 004 Funding Number: RFA PS 11 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Advances in Patient Safety through Simulation Research (R18) Apply for PAR 11 024 Funding Number: PAR 11 024 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Patient Safety and Medical Liability Reform Demonstration Projects (R18) Apply for PAR 11 025 Funding Number: PAR 11 025 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Core Violence and Injury Prevention Program (Core VIPP) Apply for CDC RFA CE11 1101 Funding Number: CDC RFA CE11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Orphans and Vulnerable Children OVC Gender Project in Botswana Apply for 674 11 0002 Funding Number: 674 11 0002 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $16,800,000 |
| The Market for Long Term Care Insurance (R01) Apply for RFA RM 11 002 Funding Number: RFA RM 11 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrating Comparative Effectiveness Research Findings into Care Delivery through Economic Incentives (R21) Apply for RFA RM 11 001 Funding Number: RFA RM 11 001 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| National Dental Practice Based Research Network Limited Competition (U19) Apply for RFA DE 12 002 Funding Number: RFA DE 12 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Minority HIV/AIDS Research Initiative (MARI) to Build Capacity in Black and Hispanic Communities and Among Black and Hispanic Researchers to Conduct HIV/AIDS Epidemiologic and Prevention Research Apply for RFA PS 11 003 Funding Number: RFA PS 11 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Translational Research Centers in Thrombotic and Hemostatic Disorders (TRC THD) (U54) Apply for RFA HL 12 008 Funding Number: RFA HL 12 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Behavioral or Social Intervention Planning and Pilot Data Grant (R34) Apply for RFA DE 12 001 Funding Number: RFA DE 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Translational Tools for Clinical Studies of Mind/Body and Manual Therapy CAM Interventions (R01) Apply for RFA AT 11 003 Funding Number: RFA AT 11 003 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R01) Apply for PA 11 033 Funding Number: PA 11 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Institutional Collaboration Between The Institute Pasteur Of Madagascar And The Centers For Disease Control And Prevention On Malaria And Vector Borne Diseases (U01) Apply for RFA GH 11 003 Funding Number: RFA GH 11 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01) Apply for RFA AA 11 006 Funding Number: RFA AA 11 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrated Health Social Marketing Program for Mozambique Apply for 656 11 001 Funding Number: 656 11 001 Agency: Mozambique USAID Maputo Category: Health Funding Amount: $20,557,019 |
| Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Resource and Support Cores (U24) Apply for RFA AA 11 007 Funding Number: RFA AA 11 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Social Science Research in Population and Reproductive Health Apply for APS OAA 10 000002 Funding Number: APS OAA 10 000002 Agency: Agency for International Development Category: Health Funding Amount: $5,000,000 |
| Sustainable Leadership, Managment and Governance RFA Apply for SOL OAA 11 000009 Funding Number: SOL OAA 11 000009 Agency: Agency for International Development Category: Health Funding Amount: $200,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA PS 11 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.